Jenburkt Pharmaceuticals Limited (NSE:JENBURPH)

Jenburkt Pharmaceuticals Revenue

Jenburkt Pharmaceuticals had revenue of 505.71M INR in the quarter ending September 30, 2026, with 11.00% growth. This brings the company's total for the last twelve months to 1.71B, up 7.60% year-over-year. In the fiscal year ending March 31, 2026, Jenburkt Pharmaceuticals had annual revenue of 1.69B with 11.24% growth.

• Revenue (ttm): 1.71B
• Revenue Growth: +7.60%
• P/S Ratio: 2.47
• Revenue / Employee: 2.14M
• Employees: 801
• Market Cap: 4.24B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• India 1.42B 84.5%
• Exports 261.20M 15.5%

Fiscal year ended Mar 31, 2026 See the full Jenburkt Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.69B	170.49M	11.24%
Mar 31, 2025	1.52B	97.25M	6.85%
Mar 31, 2024	1.42B	52.17M	3.82%
Mar 31, 2023	1.37B	127.69M	10.30%
Mar 31, 2022	1.24B	146.86M	13.44%

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error